SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 40 filers reported holding SIERRA ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $20,000 | +33.3% | 57,408 | +47.3% | 0.00% | – |
| Q3 2019 | $15,000 | +275.0% | 38,975 | +426.4% | 0.00% | – |
| Q2 2019 | $4,000 | -93.4% | 7,404 | -84.0% | 0.00% | – |
| Q4 2018 | $61,000 | -81.6% | 46,362 | -76.2% | 0.00% | – |
| Q3 2018 | $331,000 | -49.9% | 194,807 | -12.8% | 0.00% | – |
| Q2 2018 | $661,000 | +495.5% | 223,348 | +315.1% | 0.00% | – |
| Q1 2018 | $111,000 | +1287.5% | 53,807 | +947.2% | 0.00% | – |
| Q3 2017 | $8,000 | +100.0% | 5,138 | +76.9% | 0.00% | – |
| Q1 2017 | $4,000 | – | 2,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 8,112,121 | $13,872,000 | 3.34% |
| New Leaf Venture Partners, L.L.C. | 5,020,446 | $8,585,000 | 2.35% |
| Abingworth LLP | 1,365,027 | $2,307,000 | 2.06% |
| Prosight Management, LP | 2,457,683 | $4,203,000 | 1.84% |
| Broadfin Capital, LLC | 4,829,832 | $8,259,000 | 1.70% |
| MANGROVE PARTNERS IM, LLC | 3,688,609 | $6,308,000 | 0.84% |
| Vivo Capital, LLC | 2,438,270 | $4,169,000 | 0.42% |
| 683 Capital Management, LLC | 2,313,159 | $3,956,000 | 0.36% |
| PA Capital LLC | 138,082 | $236,000 | 0.25% |
| ARMISTICE CAPITAL, LLC | 1,560,000 | $2,668,000 | 0.15% |